Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000898432-25-000189
Filing Date
2025-03-17
Accepted
2025-03-17 16:45:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 5136
  Complete submission text file 0000898432-25-000189.txt   6635
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-90473 | Film No.: 25745226
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TARSADIA INVESTMENTS 520 NEWPORT CENTER DRIVE, 21ST FLOOR NEWPORT BEACH CA 92660
Business Address
Patel Tushar Bhikhubhai (Filed by) CIK: 0001745375 (see all company filings)

Type: SCHEDULE 13D/A